| HIT-COVID, a global database tracking public health interventions to COVID-19 Q Zheng, FK Jones, SV Leavitt, L Ung, AB Labrique, DH Peters, EC Lee, ... Scientific data 7 (1), 286, 2020 | 106 | 2020 |
| Current approaches to management of newly diagnosed multiple myeloma U Goel, S Usmani, S Kumar American journal of hematology 97, S3-S25, 2022 | 32 | 2022 |
| A national analysis of patterns of care and outcomes for adults diagnosed with desmoplastic small round cell tumors in the United States F Gani, U Goel, JK Canner, CF Meyer, FM Johnston Journal of surgical oncology 119 (7), 880-886, 2019 | 23 | 2019 |
| Minimally invasive versus open primary resection for retroperitoneal soft tissue sarcoma: a propensity-matched study from the National Cancer Database F Gani, U Goel, AB Blair, J Singh, HN Overton, CF Meyer, JK Canner, ... Annals of surgical oncology 25, 2209-2217, 2018 | 17 | 2018 |
| Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma C Charalampous, U Goel, SM Broski, D Dingli, P Kapoor, MA Gertz, ... Blood Advances 6 (9), 2763-2772, 2022 | 14 | 2022 |
| Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma U Goel, C Charalampous, P Kapoor, M Binder, FK Buadi, D Dingli, ... Blood cancer journal 13 (1), 11, 2023 | 9 | 2023 |
| Thrombosis in multiple myeloma: risk estimation by induction regimen and association with overall survival C Charalampous, U Goel, P Kapoor, M Binder, FK Buadi, D Dingli, ... American journal of hematology 98 (3), 413-420, 2023 | 7 | 2023 |
| Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy C Charalampous, U Goel, P Kapoor, M Binder, FK Buadi, J Cook, D Dingli, ... Blood advances 7 (16), 4371-4380, 2023 | 6 | 2023 |
| Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma C Charalampous, U Goel, M Gertz, M Lacy, A Dispenzieri, S Hayman, ... Bone Marrow Transplantation 58 (1), 46-53, 2023 | 2 | 2023 |
| Annals Graphic Medicine-Impostor Syndrome U Goel Annals of Internal Medicine 174 (7), W66-W67, 2021 | 1 | 2021 |
| Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab‐naïve relapsed multiple myeloma D Dima, R Mansour, JA Davis, M Minchak, U Goel, R Atallah, E Logan, ... European Journal of Haematology, 2024 | | 2024 |
| Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma C Charalampous, U Goel, P Kapoor, M Binder, FK Buadi, J Cook, D Dingli, ... Blood Cancer Journal 13 (1), 183, 2023 | | 2023 |
| Geographic disparities in Medicare telehealth utilization and access to specialized cancer care in the United States. U Goel, M Gautam, S Gandhi, AM Roy Journal of Clinical Oncology 41 (16_suppl), e13683-e13683, 2023 | | 2023 |
| Outcomes of patients with multiple myeloma refractory to different administration schedules of bortezomib. U Goel, C Charalampous, P Kapoor, M Binder, F Buadi, D Dingli, ... Journal of Clinical Oncology 41 (16_suppl), e20011-e20011, 2023 | | 2023 |
| Bilingual. U Goel National Medical Journal of India 36 (3), 2023 | | 2023 |
| Outcomes of Multiple Myeloma Patients Refractory to Standard Dose Vs Low Dose Lenalidomide U Goel, C Charalampous, P Kapoor, M Binder, FK Buadi, D Dingli, ... Blood 140 (Supplement 1), 9998-9999, 2022 | | 2022 |
| An update on the safety of ixazomib for the treatment of multiple myeloma U Goel, S Kumar Expert Opinion on Drug Safety 21 (9), 1143-1160, 2022 | | 2022 |
| P-207: Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma C Charalampous, U Goel, M Gertz, M Lacy, A Dispenzieri, S Hayman, ... Clinical Lymphoma, Myeloma & Leukemia 22, S149, 2022 | | 2022 |
| P-208: Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients C Charalampous, U Goel, P Kapoor, M Binder, F Buadi, D Dingli, ... Clinical Lymphoma, Myeloma & Leukemia 22, S149, 2022 | | 2022 |
| P-211: Changes in serum alkaline phosphatase levels during induction therapy to predict outcomes in patients with newly diagnosed multiple myeloma U Goel, C Charalampous, P Kapoor, M Binder, F Buadi, D Dingli, ... Clinical Lymphoma Myeloma and Leukemia 22, S151, 2022 | | 2022 |
